Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000476686 | SCV000562109 | benign | Charcot-Marie-Tooth disease type 4 | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001696812 | SCV000719367 | likely benign | not provided | 2020-11-06 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001174347 | SCV001337483 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV001286100 | SCV001472625 | benign | Charcot-Marie-Tooth disease type 4D | 2023-10-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374869 | SCV002685161 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001696812 | SCV005220000 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001286100 | SCV002085031 | likely benign | Charcot-Marie-Tooth disease type 4D | 2019-12-13 | no assertion criteria provided | clinical testing |